A citation-based method for searching scientific literature

Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park, Dong-Young Noh. Breast 2012
Times Cited: 43







List of co-cited articles
179 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
74


Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
35
45

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
205
34

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Sophie Schulz, Peter Sinn, Michael Golatta, Geraldine Rauch, Hans Junkermann, Florian Schuetz, Christof Sohn, Joerg Heil. Breast 2013
38
39



Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
54
27

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Nehmat Houssami, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto. Ann Surg Oncol 2011
30
40


Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
97
27


Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
73
23

Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ.
Edna May L Go, Siu-Ki Chan, Joaquim S L Vong, Philip C W Lui, Anthony W H Chan, Tony K F Ma, Mark A Ang, Bonita K B Law, Puay-Hoon Tan, Gary M Tse. Mod Pathol 2010
19
52

Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
251
23

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Ah Young Park, Hye Mi Gweon, Eun Ju Son, Miri Yoo, Jeong-Ah Kim, Ji Hyun Youk. Eur J Radiol 2014
31
32

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
196
23

Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus.
Jong Won Lee, Wonshik Han, Eunyoung Ko, Jihyoung Cho, Eun-Kyu Kim, So-Youn Jung, Nariya Cho, Woo Kyung Moon, In-Ae Park, Dong-Young Noh. J Surg Oncol 2008
38
23

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Caren Wilkie, Laura White, Elisabeth Dupont, Alan Cantor, Charles E Cox. Am J Surg 2005
93
20


Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.
Tomo Osako, Takuji Iwase, Masaru Ushijima, Rie Horii, Yasuyoshi Fukami, Kiyomi Kimura, Masaaki Matsuura, Futoshi Akiyama. Cancer Sci 2014
26
34

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Takafumi Kondo, Naoki Hayashi, Sachiko Ohde, Koyu Suzuki, Atsushi Yoshida, Hiroshi Yagata, Naoki Niikura, Takayuki Iwamoto, Kumiko Kida, Michiko Murai,[...]. J Surg Oncol 2015
24
37

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
185
18

Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Tomohiro Miyake, Kenzo Shimazu, Hiroshi Ohashi, Tetsuya Taguchi, Satsuki Ueda, Takahiro Nakayama, Seung Jin Kim, Katsuyuki Aozasa, Yasuhiro Tamaki, Shinzaburo Noguchi. Am J Surg 2011
32
21

Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
P Meijnen, H S A Oldenburg, C E Loo, O E Nieweg, J L Peterse, E J T Rutgers. Br J Surg 2007
64
16

Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Lisa A Rutstein, Ronald R Johnson, William R Poller, David Dabbs, Jan Groblewski, Tina Rakitt, Allan Tsung, Thomas Kirchner, Jules Sumkin, Donald Keenan,[...]. Breast J 2007
45
13

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
13

Features of occult invasion in biopsy-proven DCIS at breast MRI.
Dorota Jakubowski Wisner, E Shelley Hwang, C Belinda Chang, Hilda H Tso, Bonnie N Joe, Juan N Lessing, Ying Lu, Nola M Hylton. Breast J 2013
15
40

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
54
13

The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
Wai Ka Hung, Marcus Ying, Miranda Chan, Kong Ling Mak, Lap Kin Chan. Breast Cancer 2010
14
35

Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices.
R F Brem, J M Schoonjans, S N Goodman, A Nolten, F B Askin, O M Gatewood. Radiology 2001
55
11

The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.
Mariko Goto, Sachiko Yuen, Kentaro Akazawa, Kaori Nishida, Eiichi Konishi, Mariko Kajihara, Nobuhiko Shinkura, Kei Yamada. Eur Radiol 2012
26
19

MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Yu-Ting Huang, Yun-Chung Cheung, Yung-Feng Lo, Shir-Hwa Ueng, Wen-Ling Kuo, Shin-Cheh Chen. Acta Radiol 2011
15
33

MRI of the breast in patients with DCIS to exclude the presence of invasive disease.
Eline E Deurloo, Jincey D Sriram, Hendrik J Teertstra, Claudette E Loo, Jelle Wesseling, Emiel J Th Rutgers, Kenneth G A Gilhuijs. Eur Radiol 2012
23
21

Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy.
Jean-Charles Hogue, Lucie Morais, Louise Provencher, Christine Desbiens, Brigitte Poirier, Éric Poirier, Simon Jacob, Caroline Diorio. Anticancer Res 2014
17
29

Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
Larissa C Marques, Gustavo Nader Marta, Juliana Z de Andrade, Danúbia Andrade, Alfredo C S D de Barros, Felipe E M Andrade. Eur J Surg Oncol 2019
10
50

Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature.
Maíra Teixeira Dória, Jonathan Yugo Maesaka, Raymundo Soares de Azevedo Neto, Nestor de Barros, Edmund Chada Baracat, José Roberto Filassi. Clin Breast Cancer 2018
14
35

Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Cathal J Moran, Malcolm R Kell, Fidelma L Flanagan, Maria Kennedy, Thomas F Gorey, Michael J Kerin. Am J Surg 2007
35
11

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
B Doyle, M Al-Mudhaffer, M M Kennedy, A O'Doherty, F Flanagan, E W McDermott, M J Kerin, A D Hill, C M Quinn. J Clin Pathol 2009
30
13


A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.
Hyung Seok Park, Ha Yan Kim, Seho Park, Eun-Kyung Kim, Seung Il Kim, Byeong-Woo Park. Breast 2013
26
15

Factors associated with upstaging of ductal carcinoma in situ diagnosed by core needle biopsy using imaging guidance.
Cholatip Wiratkapun, Pachara Patanajareet, Bussanee Wibulpholprasert, Panuwat Lertsithichai. Jpn J Radiol 2011
7
57

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
C E Cox, K Nguyen, R J Gray, C Salud, N N Ku, E Dupont, L Hutson, E Peltz, G Whitehead, D Reintgen,[...]. Am Surg 2001
166
9

Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
Y Wahedna, A J Evans, S E Pinder, I O Ellis, R W Blamey, J G Geraghty. Eur J Cancer 2001
27
14

The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy.
Lidewij E Hoorntje, Marguerite E I Schipper, Petra H M Peeters, Frank Bellot, Remmert K Storm, Inne H M Borel Rinkes. Ann Surg Oncol 2003
66
9

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Laura Chin-Lenn, Lloyd A Mack, Walley Temple, William Cherniak, Robert R Quinn, Pietro Ravani, Adriane M Lewin, May Lynn Quan. Ann Surg Oncol 2014
25
16


American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred, Richard J Cote, Mitchell Dowsett, Patrick L Fitzgibbons, Wedad M Hanna, Amy Langer,[...]. J Clin Oncol 2007
9




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.